Flurazepam Hydrochloride Capsule Shortage: Current FDA Status and Availability Updates

What’s in Shortage

Flurazepam Hydrochloride is currently listed in the FDA Drug Shortage Database. This medication, available under the brand name FLURAZEPAM HYDROCHLORIDE, is provided in capsule form. It is categorized under Oncology and Other therapeutic categories. The shortage was first posted on August 3, 2022, and the status was last updated on February 2, 2026.

Which Manufacturers Are Affected

Currently, the following manufacturer is listed with the associated availability status for Flurazepam Hydrochloride capsules:

• Chartwell Molecular Holdings LLC
  • Status: Available
  • Presentations:
    • 15 mg Capsule (NDC 62135-736-90)
    • 15 mg Capsule (NDC 62135-736-30)
    • 30 mg Capsule (NDC 62135-737-90)
    • 30 mg Capsule (NDC 62135-737-30)
  • Contact Information: 845-268-5000 Ext. 510

Why There’s a Shortage

The FDA source data does not provide a specific reason for the current shortage status of Flurazepam Hydrochloride capsules.

What Patients Should Do

If you are prescribed Flurazepam Hydrochloride and are having difficulty filling your prescription, please consider the following steps:

• Consult Your Healthcare Provider: Speak with your doctor regarding your treatment plan. Do not make any changes to your medication regimen without professional medical advice.
• Talk to Your Pharmacist: Your pharmacist may have information on local stock levels or may be able to assist in locating the medication from different suppliers.
• Contact the Manufacturer: You may reach out to Chartwell Molecular Holdings LLC at 845-268-5000 Ext. 510 for further information regarding their current supply.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medication availability and treatment alternatives.

Source

Information provided by the FDA Drug Shortage Database.